Owing to the growing number of clinical trials and complexities associated with patient enrollment, drug developers are increasingly relying on patient recruitment service providers to expediate the drug development timelines


Roots Analysis is pleased to announce the publication of its recent study, titled, “Patient Recruitment and Retention Services Market (3rd Edition), 2022 – 2035.”


The report features an extensive study of companies engaged in offering patient recruitment services and patient retention services. The study features an in-depth analysis of the key drivers and trends related to this domain. Amongst other elements, the report includes:

  • A general overview of the clinical trials, patient recruitment process, patient recruitment associated services as well as the patient retention strategies employed to prevent drop-out of enrolled individuals from clinical trials.
  • A brief information on the various types of patient outreach methods used by contract service providers in this domain, to identify and enroll patients in clinical trials.
  • A detailed assessment of the overall landscape of companies offering patient recruitment and patient retention services.
  • A detailed competitiveness analysis of patient recruitment and retention service providers, segregated into three peer groups based on company size (small, mid-sized, and large and very large).
  • Elaborate profiles of prominent players offering patient recruitment and retention service, based in North America, Europe and Asia Pacific.
  • An analysis of the partnerships that have been inked by stakeholders engaged in this domain, from 2013-2022.
  • A review of the emerging trends in the patient recruitment industry, including the use of social media, mobile technologies, electronic health records (EHR), real-world evidence (RWE) and artificial intelligence.
  • A detailed discussion on the key growth opportunities in the field of patient recruitment and retention that are likely to impact the evolution of the market over the coming years.
  • A case study on regulatory landscape of patient recruitment, highlighting the regulatory process, guidelines and framework.
  • A brief overview of patient recruitment in clinical trials focused on personalized medicines and rare diseases.
  • A detailed analysis of the annual demand for study participants, taking into account the target patient population in ongoing and planned clinical trials, sponsored by both industry and non-industry players.
  • A detailed assessment on the impact of the COVID-19 pandemic on the patient recruitment and retention services market.
  • A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
  • Patient Recruitment Step
  • Pre-screening
  • Screening


  • Trial Phase
  • Phase I
  • Phase II
  • Phase III
  • Phase IV


  • Therapeutic Area
  • Cardiovascular Disorders
  • Oncological Disorders
  • Infectious Diseases
  • CNS Disorders
  • Respiratory Disorders
  • Hematological Disorders
  • Dermatological Disorders
  • Ophthalmic Disorders
  • Others


  • Key Geographical Regions
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and North Africa
  • Rest of the World 


To get a sample copy of the latest market report, visit



Transcripts of interviews held with the following senior level representatives of stakeholder companies:

  • Susan Fitzpatrick-Napier (Founder and Director, TrialWire)
  • Kate Shaw (Chief Executive Officer and Founder) and Marco Lassandro (Marketing and Communications Manager, Innovative Trials)
  • Simon Klaasen (Co-founder and Managing Director, Link2Trials)
  • Stefan Mayer-Eggersmann (Chief Commercial Officer, Clariness)
  • Ken Shore (Chief Commercial Officer, Continuum Clinical)
  • Hagit Nof (Chief Operation Officer and Business Development Officer, nRollmed)
  • Paul Ivsin (Ex-Managing Director, Seeker Health)
  • Kasturi Lakhe (Inside Sales Specialist, EVERSANA)


Key companies covered in the report

  • BBK Worldwide
  • Continuum Clinical
  • United BioSource (UBC)
  • WCG ThreeWire
  • Clariness
  • Fidelis Research
  • Ignite Data
  • Innovative Trials
  • Orphan Reach
  • 3H Medi Solution
  • Buzzreach
  • Current Medical Information Center (CMIC)
  • nRollmed
  • Trialfacts


To view more details on this report, click on the link:



You may also be interested in the following titles:

Oral Proteins and Peptides Market

Single-Use Upstream Bioprocessing Technology / Equipment Market


About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.



Ben Johnson

+1 (415) 800 3415

+44 (122) 391 1091



Be the first person to like this.